Skip to main content
Equibles

RDHL · RedHill Biopharma Ltd. · Investor Relations

Track RDHL — free

Use RDHL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RDHL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.50 +0.01 (+1.42%)
Rebalance outlook locked
Market Cap
$3.04M
Shares
6.08M
Volume · Oct 6 57.87K Avg daily vol (3M) 1.79M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-09 00:00 UTC BIO-Europe 2026 Event

Recent news

Date Headline
2026-09-30 RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
2026-09-01 RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
2026-08-31 RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
2026-07-28 Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
2026-06-22 RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
2026-06-18 RedHill Biopharma Announces Up To $19.4 Million Private Placement
2026-06-09 RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
2026-06-08 RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
2026-06-02 RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
2026-04-30 RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
2026-04-27 RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
2026-04-22 RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
2026-02-25 Joint U.S. Commercialization of RedHill's Talicia® Commences
2026-01-05 RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
2025-12-15 RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

Past events

Date Event Type
2026-08-06 Annual General Meeting of Shareholders Shareholder meeting
2026-06-22 BIO International Convention 2026 Event
2026-03-23 BIO-Europe Spring Event
2026-03-05 Extraordinary General Meeting of Shareholders Shareholder meeting
2026-03-02 BIO Investment and Growth Summit Event
2025-11-03 BIO-EUROPE, 3 - 5th November, Vienna, Austria Event
2025-10-08 Sachs 25th Annual Biotech in Europe Forum Event
2025-06-16 BIO International Convention 2025 Event
2025-05-05 2025 Annual General Meeting of Shareholders Shareholder meeting
2025-02-26 18th Annual European Life Sciences CEO Forum (Sachs_ELSF) Event
2024-06-03 BIO International Convention 2024 Event
2024-05-31 ASCO Annual Meeting 2024 Shareholder meeting
2024-05-08 Aegis Capital Virtual Conference Conference
2022-11-21 2nd International Conference on Microbiology & Infectious Diseases Conference
2022-10-21 American College of Gastroenterology Annual Meeting (ACG) Shareholder meeting
2022-09-12 H.C. Wainwright 24th Annual Global Investment Conference Conference
2022-08-17 World Gastro 2022 Event
2022-08-07 International Conference on Emerging Infectious Diseases (ICEID) Conference
2022-07-13 2nd ARDS Drug Development Summit Event
2022-06-23 First Quarter 2022 Financial Results & Operational Highlights Webcast Earnings call
2022-05-24 H.C. Wainwright Global Investment Conference Conference
2022-05-13 RedHill Biopharma Annual General Meeting of Shareholders Shareholder meeting
2022-03-29 2022 Cantor Virtual Rare Orphan Disease Summit Event
2022-03-28 BIO-Europe Spring 2022 Digital Conference Conference
2022-03-17 Q4 & Full Year 2021 Financial Results Conference Call & Webcast Earnings call

Source: https://www.redhillbio.com/investors/overview/default.aspx

Key facts CIK 1553846 CUSIP 757468301 Visit website Investor relations